These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Methodology validation, intra-subject reproducibility and stability of exhaled volatile organic compounds. Basanta M; Ibrahim B; Douce D; Morris M; Woodcock A; Fowler SJ J Breath Res; 2012 Jun; 6(2):026002. PubMed ID: 22549110 [TBL] [Abstract][Full Text] [Related]
3. Investigations on the variability of breath gas sampling using PTR-MS. Thekedar B; Szymczak W; Höllriegl V; Hoeschen C; Oeh U J Breath Res; 2009 Jun; 3(2):027007. PubMed ID: 21383462 [TBL] [Abstract][Full Text] [Related]
4. Exhaled breath profiling enables discrimination of chronic obstructive pulmonary disease and asthma. Fens N; Zwinderman AH; van der Schee MP; de Nijs SB; Dijkers E; Roldaan AC; Cheung D; Bel EH; Sterk PJ Am J Respir Crit Care Med; 2009 Dec; 180(11):1076-82. PubMed ID: 19713445 [TBL] [Abstract][Full Text] [Related]
5. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath. Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903 [TBL] [Abstract][Full Text] [Related]
6. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis. Dallinga JW; Smolinska A; van Schooten FJ Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934 [TBL] [Abstract][Full Text] [Related]
7. Chronic intestinal Mycobacteria infection: discrimination via VOC analysis in exhaled breath and headspace of feces using differential ion mobility spectrometry. Purkhart R; Köhler H; Liebler-Tenorio E; Meyer M; Becher G; Kikowatz A; Reinhold P J Breath Res; 2011 Jun; 5(2):027103. PubMed ID: 21512209 [TBL] [Abstract][Full Text] [Related]
8. An electronic nose in the discrimination of patients with non-small cell lung cancer and COPD. Dragonieri S; Annema JT; Schot R; van der Schee MP; Spanevello A; Carratú P; Resta O; Rabe KF; Sterk PJ Lung Cancer; 2009 May; 64(2):166-70. PubMed ID: 18834643 [TBL] [Abstract][Full Text] [Related]
10. Optimisation of sampling parameters for standardised exhaled breath sampling. Doran SLF; Romano A; Hanna GB J Breath Res; 2017 Dec; 12(1):016007. PubMed ID: 29211685 [TBL] [Abstract][Full Text] [Related]
11. The versatile use of exhaled volatile organic compounds in human health and disease. Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865 [TBL] [Abstract][Full Text] [Related]
12. The analysis of volatile organic compounds biomarkers for lung cancer in exhaled breath, tissues and cell lines. Wang Y; Hu Y; Wang D; Yu K; Wang L; Zou Y; Zhao C; Zhang X; Wang P; Ying K Cancer Biomark; 2012; 11(4):129-37. PubMed ID: 23144150 [TBL] [Abstract][Full Text] [Related]
13. An adaptive breath sampler for use with human subjects with an impaired respiratory function. Basanta M; Koimtzis T; Singh D; Wilson I; Thomas CL Analyst; 2007 Feb; 132(2):153-63. PubMed ID: 17260076 [TBL] [Abstract][Full Text] [Related]
14. Novel extraction of volatile biomarkers from canine breath for gas chromatography-mass spectrometry. Dissanayake S; Lathan P; Mlsna T J Breath Res; 2012 Dec; 6(4):041001. PubMed ID: 22989995 [TBL] [Abstract][Full Text] [Related]
15. Optimization of sampling parameters for collection and preconcentration of alveolar air by needle traps. Filipiak W; Filipiak A; Ager C; Wiesenhofer H; Amann A J Breath Res; 2012 Jun; 6(2):027107. PubMed ID: 22621839 [TBL] [Abstract][Full Text] [Related]
16. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study. Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121 [TBL] [Abstract][Full Text] [Related]
17. Development of a protocol to measure volatile organic compounds in human breath: a comparison of rebreathing and on-line single exhalations using proton transfer reaction mass spectrometry. O'Hara ME; O'Hehir S; Green S; Mayhew CA Physiol Meas; 2008 Mar; 29(3):309-30. PubMed ID: 18367807 [TBL] [Abstract][Full Text] [Related]
19. Respiratory symptoms and peak expiratory flow in children with asthma in relation to volatile organic compounds in exhaled breath and ambient air. Delfino RJ; Gong H; Linn WS; Hu Y; Pellizzari ED J Expo Anal Environ Epidemiol; 2003 Sep; 13(5):348-63. PubMed ID: 12973363 [TBL] [Abstract][Full Text] [Related]
20. Analysis of volatile organic compounds in the breath of patients with stable or acute exacerbation of chronic obstructive pulmonary disease. Pizzini A; Filipiak W; Wille J; Ager C; Wiesenhofer H; Kubinec R; Blaško J; Tschurtschenthaler C; Mayhew CA; Weiss G; Bellmann-Weiler R J Breath Res; 2018 Mar; 12(3):036002. PubMed ID: 29295966 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]